U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07255508) titled 'Efficacy of Prostatic Arteries Embolization Using SQUIDPERI' on Nov. 20.
Brief Summary: Prostatic Artery Embolization (PAE) is a recognized mini-invasive treatment of bothersome Lower Urinary Tract Symptoms (LUTS) related to Benign Prostatic Hyperplasia (BPH). Particle embolics are used almost exclusively for embolization, with wide variation in the type and size of particles showing similar performance and safety results. Even if its durability relies on multiple risk factors, LUTS recurrence-free survival probability decreases with years. It is demonstrated that recanalization of the native prostatic artery is found in 66% of patie...